Frank Rimerman Advisors’s Idexx Laboratories IDXX Stock Holding History

Frank Rimerman Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$300K	Sell	534 -461	-46%	-$296K	0.02%	496
2025 Q4	$673K	Buy	995 +444	+81%	+$302K	0.04%	311
2025 Q3	$352K	Buy	551 +53	+11%	+$32.2K	0.02%	446
2025 Q2	$267K	Sell	498 -252	-34%	-$121K	0.02%	483
2025 Q1	$315K	Buy	750 +235	+46%	+$102K	0.03%	398
2024 Q4	$213K	Sell	515 -20	-4%	-$8.77K	0.02%	494
2024 Q3	$270K	Buy	535 +15	+3%	+$7.29K	0.02%	447
2024 Q2	$253K	Buy	+520	New	+$261K	0.02%	481

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frank Rimerman Advisors's IDXX Position: Q1 2026 in Review

Frank Rimerman Advisors reduced its Idexx Laboratories (IDXX) stake by 46% in Q1 2026, selling an estimated $296K and leaving 534 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #496.

Frank Rimerman Advisors first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $673K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Frank Rimerman Advisors held 534 shares of Idexx Laboratories worth $300K as of Q1 2026.
Frank Rimerman Advisors sold 461 Idexx Laboratories shares in Q1 2026, an estimated $296K.
Idexx Laboratories made up 0.02% of Frank Rimerman Advisors's portfolio in Q1 2026, its #496 holding.
Frank Rimerman Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
Frank Rimerman Advisors's Idexx Laboratories position peaked at $673K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.